[Federal Register Volume 85, Number 214 (Wednesday, November 4, 2020)]
[Notices]
[Pages 70211-70213]
[FR Doc No: 2020-24481]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Investment Company Act Release No. 34081]

Notice of Applications for Deregistration Under Section 8(f) of
the Investment Company Act of 1940

October 30, 2020.
    The following is a notice of applications for deregistration under
section 8(f) of the Investment Company Act of 1940 for the month of
October 2020. A copy of each application may be obtained via the
Commission's website by searching for the file number, or for an
applicant using the Company name box, at http://www.sec.gov/search/search.htm or by calling<PHONE_NUMBER>. An order granting each
application will be issued unless the SEC orders a hearing. Interested
persons may request a hearing on any application by emailing the SEC's
Secretary at<EMAIL_ADDRESS>and serving the relevant
applicant with a copy of the request by email, if an email address is
listed for the relevant applicant below, or personally or by mail, if a
physical address is listed for the relevant applicant below. Hearing
requests should be received by the SEC by 5:30 p.m. on November 24,
2020, and should be accompanied by proof of service on applicants, in
the form of an affidavit or, for lawyers, a certificate of service.
Pursuant to Rule 0-5 under the Act, hearing requests should state the
nature of the writer's interest, any facts bearing upon the
desirability of a hearing on the matter, the reason for the request,
and the issues contested. Persons who wish to be notified of a hearing
may request notification by writing to the Commission's Secretary at
<EMAIL_ADDRESS>
ADDRESSES: The Commission<EMAIL_ADDRESS>
FOR FURTHER INFORMATION CONTACT: Shawn Davis, Assistant Director, at
(202) 551-6413 or Chief Counsel's Office at<PHONE_NUMBER>; SEC,
Division of Investment Management, Chief Counsel's Office, 100 F Street
NE, Washington, DC 20549-8010.

Angel Oak Financial Institutions Income Term Trust [File No. 811-23327]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. Applicant has
never made a public offering of its securities and does not propose to
make a public offering or engage in business of any kind.
    Filing Date: The application was filed on August 4, 2020, and
amended on October 23, 2020.
    Applicant's Address<EMAIL_ADDRESS>
CC Real Estate Income Fund [File No. 811-23109]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. On August 6,
2020, applicant made liquidating distributions to its shareholders
based on net asset value. Expenses of $2,649 incurred in connection
with the liquidation were paid by the applicant or applicant's
investment adviser. Applicant also has retained $18,038 for the purpose
of paying outstanding obligations.
    Filing Date: The application was filed on August 18, 2020.
    Applicant's Address<EMAIL_ADDRESS>
CC Real Estate Income Fund-ADV [File No. 811-23260]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. On August 6,
2020, applicant made liquidating distributions to its shareholders
based on net asset value. Expenses of $316 incurred in connection with
the liquidation were paid by the applicant or applicant's investment
adviser. Applicant also has retained $4,962 for the purpose of paying
outstanding obligations.
    Filing Date: The application was filed on August 18, 2020.
    Applicant's Address<EMAIL_ADDRESS>
CC Real Estate Income Fund-T [File No. 811-23133]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. On August 6,
2020, applicant made liquidating distributions to its shareholders
based on net asset value. Expenses of $1,483 incurred in connection
with the liquidation were paid by the applicant. Applicant also has
retained $13,603 for the purpose of paying outstanding obligations.
    Filing Date: The application was filed on August 18, 2020, and
amended on October 23, 2020.
    Applicant's Address<EMAIL_ADDRESS>
Cushing Energy Income Fund [File No. 811-22593]

    Summary: Applicant, a closed-end investment company, seeks an order

declaring that it has ceased to be an investment company. The applicant
has transferred its assets to Cushing MLP & Infrastructure Total Return
Fund and, on May 29, 2020, made a final distribution to its
shareholders based on net asset value. Expenses of $119,536 incurred in
connection with the reorganization were paid by the applicant.
    Filing Date: The application was filed on June 1, 2020.
    Applicant's Address<EMAIL_ADDRESS>
Goldman Sachs Private Markets Fund 2018 (A) LLC [File No. 811-23300]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. Applicant has
never made a public offering of its securities and does not propose to
make a public offering or engage in business of any kind.
    Filing Dates: The application was filed on August 23, 2019, and
amended on August 14, 2020.
    Applicant's Address<EMAIL_ADDRESS>
Goldman Sachs Private Markets Fund 2018 (B) LLC [File No. 811-23302]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. Applicant has
never made a public offering of its securities and does not propose to
make a public offering or engage in business of any kind.
    Filing Dates: The application was filed on August 23, 2019, and
amended on August 14, 2020.
    Applicant's Address<EMAIL_ADDRESS>
Goldman Sachs Private Markets Fund 2018 LLC [File No. 811-23301]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. Applicant has
never made a public offering of its securities and does not propose to
make a public offering or engage in business of any kind.
    Filing Dates: The application was filed on August 23, 2019, and
amended on August 14, 2020.
    Applicant's Address<EMAIL_ADDRESS>
Icon Funds [File No. 811-07883]

    Summary: Applicant seeks an order declaring that it has ceased to
be an investment company. The applicant has transferred its assets to
SCM Trust, and on June 30, 2020, July 9, 2020, and September 24, 2020,
made final distributions to its shareholders based on net asset value.
Expenses of $246,000 incurred in connection with the reorganization
were paid by the applicant.
    Filing Date: The application was filed on September 29, 2020.
    Applicant's Address<EMAIL_ADDRESS>
Independence Variable Annuity Separate Account [File No. 811-05232]

    Summary: Applicant, a unit investment trust, seeks an order
declaring that it has ceased to be an investment company. Applicant has
never made a public offering of its securities and does not propose to
make a public offering or engage in business of any kind.
    Filing Date: The application was filed on July 13, 2020.
    Applicant's Address<EMAIL_ADDRESS>
Jackson Variable Series Trust [File No. 811-22613]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. Applicant has
never made a public offering of its securities and does not propose to
make a public offering or engage in business of any kind.
    Filing Date: The application was filed on September 18, 2020.
    Applicant's Address<EMAIL_ADDRESS>
JNL Variable Fund LLC [File No. 811-09121]

    Summary: Applicant seeks an order declaring that it has ceased to
be an investment company. The applicant has transferred its assets to
JNL Series Trust, and on April 27, 2020 made a final distribution to
its shareholders based on net asset value. Expenses of $13,655.50
incurred in connection with the reorganization were paid by the
applicant's investment advisor.
    Filing Date: The application was filed on September 18, 2020.
    Applicant's Address<EMAIL_ADDRESS>
Legg Mason Permal Alternatives Fund Inc. [File No. 811-22537]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. Applicant has
never made a public offering of its securities and does not propose to
make a public offering or engage in business of any kind.
    Filing Dates: The application was filed on September 20, 2019, and
amended on October 9, 2020.
    Applicant's Address<EMAIL_ADDRESS>
Pine Grove Alternative Institutional Fund [File No. 811-22860]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. On August 1,
2019, and June 4, 2020, applicant made liquidating distributions to its
shareholders based on net asset value. Expenses of $48,100 incurred in
connection with the liquidation were paid by the applicant's investment
adviser.
    Filing Dates: The application was filed on July 14, 2020, and
amended on October 19, 2020.
    Applicant's Address<EMAIL_ADDRESS>
Reliastar Life Ins Co of NY Variable Annuity Funds A B & C [File No.
811-02579]

    Summary: Applicant, a unit investment trust, seeks an order
declaring that it has ceased to be an investment company. No expenses
were incurred in connection with the liquidation.
    Filing Dates: The application was filed on October 21, 2019, and
amended on September 21, 2020.
    Applicant's Address<EMAIL_ADDRESS>
Victory Institutional Funds [File No. 811-21584]

    Summary: Applicant seeks an order declaring that it has ceased to
be an investment company. On April 26, 2019, applicant made a
liquidating distribution to its shareholders based on net asset value.
Expenses of $2,500 incurred in connection with the reorganization were
paid by the applicant. Applicant has also retained $287 for the purpose
of paying outstanding liabilities.
    Filing Dates: The application was filed on October 9, 2019, and
amended on August 28, 2020.
    Applicant's Address<EMAIL_ADDRESS>and<PHONE_NUMBER>0f04132117020c4f020e0c.

Western Asset Opportunistic Income Fund Inc. [File No. 811-22787]

    Summary: Applicant, a closed-end investment company, seeks an order
declaring that it has ceased to be an investment company. Applicant has
never made a public offering of its securities and does not propose to
make a public offering or engage in business of any kind.

    Filing Dates: The application was filed on September 20, 2019, and
amended on October 9, 2020.
    Applicant's Address<EMAIL_ADDRESS>
    For the Commission, by the Division of Investment Management,
pursuant to delegated authority.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2020-24481 Filed 11-3-20; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 81, Number 203 (Thursday, October 20, 2016)]
[Notices]
[Pages 72593-72594]
[FR Doc No: 2016-25359]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-D-0530]

Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Pre-Submission
Program for Medical Devices

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by
November 21, 2016.

ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX:<PHONE_NUMBER>, or emailed to<EMAIL_ADDRESS>All
comments should be identified with the OMB control number 0910-0756.
Also include the FDA docket number found in brackets in the heading of
this document.

FOR FURTHER INFORMATION CONTACT: FDA PRA Staff, Office of Operations,
Food and Drug Administration, Three White Flint North 10A63, 11601
Landsdown St., North Bethesda, MD 20852<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.

Pre-Submission Program for Medical Devices--OMB Control Number 0910-
0756--Extension

    The guidance entitled ``Requests for Feedback on Medical Device
Submissions: The Pre-Submission Program and Meetings with Food and Drug
Administration Staff'' describes the Pre-Submission program for medical
devices reviewed in the Center for Devices and Radiological Health
(CDRH) and the Center for Biologics Evaluation and Research (CBER). The
guidance provides recommendations regarding the information that should
be submitted in a Pre-Submission package and procedures that should be
followed for meetings between CDRH and CBER staff and industry
representatives or application sponsors. In addition to Pre-
Submissions, the guidance addresses other feedback mechanisms including
Informational Meetings, Study Risk Determinations, Formal Early
Collaboration Meetings, and Submission Issue Meetings and the
procedures to request feedback using these mechanisms.
    A Pre-Submission is defined as a formal written request from an
applicant for feedback from FDA to be provided in the form of a formal
written response or, if the manufacturer chooses, a meeting or
teleconference in which the feedback is documented in meeting minutes.
A Pre-Submission is appropriate when FDA's feedback on specific
questions is necessary to guide product development and/or application
preparation. The proposed collections of information are necessary to
allow the Agency to receive Pre-Submission packages in order to
implement this voluntary submission program.
    For clarity, we are requesting that the title of the information
collection request, OMB control number 0910-0756, be changed to ``Pre-
Submission Program for Medical Devices.''
    In the Federal Register of July 28, 2016 (81 FR 49678), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. No comments were received.
    FDA estimates the burden of this collection of information as
follows:

                                 Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                      Annual
           FDA center                Number of     frequency per   Total annual      Hours per      Total hours
                                    respondents      response        responses       response
----------------------------------------------------------------------------------------------------------------
CDRH............................           2,465               1           2,465             137         337,705
CBER............................              79               1              79             137          10,823
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............         348,528
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

    Respondents are medical device manufacturers subject to FDA's laws
and regulations. FDA's annual estimate of 2,544 submissions is based on
experienced trends over the past several years. FDA's administrative
and technical staffs, who are familiar with the requirements for
current Pre-Submissions, estimate that an average of 137 hours is
required to prepare a Pre-Submission.

    Dated: October 13, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-25359 Filed 10-19-16; 8:45 am]
 BILLING CODE 4164-01-P


MEMORANDUM

To:		Docket EPA - HQ - OAR - 2010 - 0505

From: 	Karen Marsh, U.S. EPA, OAQPS, Sector Policies and Programs Division

--------------------------------------------------------------------------------
Subject:	Meeting with the Center for Methane Emission Solutions (CMES)
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------
Date: 	January 24, 2018
--------------------------------------------------------------------------------

On December 6, 2017, EPA had a meeting with members from the Center for Methane Emission Solutions (CMES). CMES is a coalition of companies in the methane mitigation industry. Various solutions were discussed related to ways to address methane emissions. Handouts provided at the meeting at attached.

The following individuals attended the meeting:

Isaac Brown, Deputy Director, the Center for Methane Emission Solutions
Hannah Cooper, John Crane
Craig O'Neil, FLIR

EPA:
David Cozzie
Mark DeFigueiredo
Alex Dominguez
Sarah Dunham
Paul Gunning
David Harlow
Karen Marsh
Peter Tsirigotis